Please login to the form below
Pharmalink
This page shows the latest Pharmalink news and features for those working in and with pharma, biotech and healthcare.
Pharmalink appoints new chairman Anders Wiklund
Anders Wiklund has joined Swedish specialty pharma company Pharmalink AB as chairman of the board. ... Julander, who founded the company in 1991, will remain on Pharmalink's board as a non-executive director, as will Lennart Hansson.
Latest news
-
News in brief, July 04, 2007
Eli Lilly divests Distaclor antibiotic. The Indian subsidiary of global pharmaceutical major Eli Lilly has divested its antibiotic Distaclor (cefaclor) to Pharmalink, a subsidiary of Quintiles International, for an undisclosed sum,
More from news
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest appointments
-
ReNeuron appoints new CEO
Hellebø, who has also previously held directorship positions at Pharmalink and Palma Biotech, said ReNeuron impressed him with their technology, team and strong investment backing.
-
Pharmalink appoints Dr Heather Cook and Marek Poszepczynski
Strengthens senior management team. Pharmalink has bolstered its senior management team with the appointment of Dr Heather Cook and Marek Poszepcynski (pictured). ... Pharmalink's other senior management appointment is Marek Poszepcynski who takes up
More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- bluebird bio reveals plans to launch two gene therapies
- Sanofi halts recruitment for trials assessing MS treatment
- Eli Lilly to make bebtelovimab commercially available to US states from August
- The patient voice – the value of patient-reported outcomes in HTA
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- ONS records a continued fall in UK COVID-19 infections
- Powering Rapid Cognitive Analysis with AI
- How the Royal Society’s EiR programme can help to drive UK innovation
- BMS and 2seventy bio announce positive results for multiple myeloma treatment
- Roche and Cend Therapeutics to evaluate pancreatic cancer combination therapy
- Aqilion initiates phase 1 clinical trial for chronic inflammatory diseases
- JCVI publishes statement on London polio vaccination strategy
- Eli Lilly to make bebtelovimab commercially available to US states from August
- Amgen acquires ChemoCentryx in $3.7bn cash deal
- AstraZeneca’s Alexion agrees on $775m settlement with Chugai for Ultomiris
- EMA backs adjuvant use of Roche’s breast cancer ADC Kadcyla
- FDA approves Coherus’ Cimerli as biosimilar interchangeable with Lucentis for all five indications
- Gilead Sciences set to acquire MiroBio in deal worth over $400m
PMHub
Langland
Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...
